Market revenue in 2023 | USD 70.6 million |
Market revenue in 2030 | USD 103.1 million |
Growth rate | 5.6% (CAGR from 2023 to 2030) |
Largest segment | Kits |
Fastest growing segment | Kits |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Reagents, Kits |
Key market players worldwide | Merck KGaA, Croda International PLC, CordenPharma, NOF Corp, Echelon Biosciences, BroadPharm, Tebubio, Creative-Biolabs, Biopharma PEG Scientific Inc., Polysciences |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to lipid nanoparticle raw materials market will help companies and investors design strategic landscapes.
Kits was the largest segment with a revenue share of 54.96% in 2023. Horizon Databook has segmented the Europe lipid nanoparticle raw materials market based on reagents, kits covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe lipid nanoparticle raw materials market, including forecasts for subscribers. This continent databook contains high-level insights into Europe lipid nanoparticle raw materials market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account